This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Value Trader Highlights: Arch Capital, CAN, Allstate, Progressive and Travelers
by Zacks Equity Research
Zacks Value Trader Highlights: Arch Capital, CAN, Allstate, Progressive and Travelers
Allstate (ALL) Down 2.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Hide Out in Cheap Insurance Stocks?
by Tracey Ryniec
Insurance may seem boring but there's a reason its been around for hundreds of years. Are the fundamentals still solid?
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Expects to Incur Catastrophe Loss for April
by Zacks Equity Research
Allstate (ALL) expects to incur $290 million pre-tax catastrophe loss for April, which can be attributed to seven weather-related events.
Why Allstate (ALL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Q1 Earnings Beat Despite Catastrophe Loss
by Zacks Equity Research
Allstate's (ALL) Q1 results benefit from increase in revenues, partly offset by loss due to catastrophe.
Allstate (ALL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 0.44% and 15.22%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Allstate (ALL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Allstate (ALL) Q1 earnings to benefit from higher revenues, partly offset by rise in expenses.
What Awaits Intercontinental Exchange (ICE) in Q1 Earnings?
by Zacks Equity Research
Intercontinental Exchange's (ICE) first-quarter results are likely to benefit from a broad range of risk management services on an integrated platform
CME Group (CME) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group (CME) is likely to benefit from expansion of futures products in emerging markets, options business, non-transaction related opportunities and OTC offerings.
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
What's in Store for Lincoln National (LNC) in Q1 Earnings?
by Zacks Equity Research
Lincoln National (LNC) Q1 earnings to gain from higher revenues, partly offset by rise in expenses.
CNA Financial (CNA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CNA Financial's (CNA) first-quarter results are likely to benefit from solid performances from its segments - Commercial and Specialty.
Allstate (ALL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate
What's in the Offing for Aon (AON) This Earnings Season?
by Zacks Equity Research
Aon's (AON) first-quarter earnings are likely to benefit from solid segmental performances.
Top Research Reports for Roche, Danaher & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Roche (RHHBY), Danaher (DHR) and BlackRock (BLK).
Arthur J. Gallagher (AJG) to Report Q1 Earnings: What's Up?
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q1 results will likely benefit from solid segmental performance.
Will Cincinnati Financial (CINF) Q1 Earnings Beat Estimates?
by Zacks Equity Research
Cincinnati Financial (CINF) Q1 earnings will likely benefit form solid policy retention, increase in average renewal price and agent-focused business model.
What's in the Cards for Marsh & McLennan (MMC) Q1 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results are likely to gain from a solid revenue contribution.
Will Aflac (AFL) Retain Positive Earnings Surprise in Q1?
by Zacks Equity Research
Aflac (AFL) Q1 earnings to gain from US segment's higher contribution, partly offset by subdued results from Japan unit.
Is a Beat in the Cards for Synchrony Financial Q1 Earnings?
by Zacks Equity Research
Synchrony Financial's (SYF) first-quarter earnings are likely to grow on the back of higher purchase volume and CareCredit platform.
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.